Log In
BCIQ
Print this Print this
 

BXQ-350

  Manage Alerts
Collapse Summary General Information
Company Bexion Pharmaceuticals LLC
DescriptionNanovesicle formulation of lysosomal protein saposin C and the phospholipid dioleoylphosphatidylserine (DOPS)
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today